Faculty, staff, students and trainees gathered for the ninth annual Les Turner Symposium on ALS and NeuroRepair, a one-day event highlighting the present and future of treating ALS.
Northwestern has formed the Center for Translational Pain Research, which aims to advance basic and clinical science in the hopes of developing non-addictive treatments for chronic pain.
A new $10 million gift from Northwestern University trustees and supporters Louis A. Simpson ’58 and Kimberly K. Querrey will support a center now known as the Simpson Querrey Center for Neurogenetics.
Evangelos Kiskinis, PhD, has received a New York Stem Cell Foundation – Robertson Investigator Award to study the origins of ALS and pediatric epilepsy.
A cancer drug that washed out of clinical trials more than 15 years ago may be the key to slowing the progression of Parkinson’s disease, according to a Northwestern Medicine study.
High levels of folate, a B vitamin, can force glial nerve cells to transform back into undifferentiated stem cells, according to a new study published in the journal Stem Cells.
Northwestern Medicine scientists have developed a new strategy to treat Parkinson’s disease by mitigating the effects of harmful genetic mutations, according to a recent study.
Joel Voss, PhD, and John Disterhoft, PhD, have received a $6.3 million grant from the NIH as part of the BRAIN Initiative.
A recent investigation published in Nature Communications revealed how damage to a neural circuit can cause amnesia.